Subscribe To
IVVD / Invivyd, Inc. (IVVD) CEO David Hering on Q3 2022 Results - Earnings Call Transcript
IVVD News
By Zacks Investment Research
August 29, 2023
Invivyd (IVVD) Stock Rises 18% in 3 Months: Here's Why
Invivyd's (IVVD) shares rallied almost 18% over the past three months, owing to promising developments in its monoclonal antibody candidate, VYD222, d more_horizontal
By Seeking Alpha
August 12, 2023
Invivyd, Inc. (IVVD) Q2 2023 Earnings Call Transcript
Invivyd, Inc. (NASDAQ:IVVD ) Q2 2023 Earnings Conference Call August 10, 2023 4:30 PM ET Company Participants Gabriella Linville-Engler - Investor Rel more_horizontal
By Seeking Alpha
March 25, 2023
Invivyd, Inc (IVVD) Q4 2022 Earnings Call Transcript
Invivyd, Inc (NASDAQ:IVVD ) Q4 2022 Earnings Conference Call March 23, 2023 4:30 PM ET Company Participants Kyra Faircloth - Investor Relations Dave H more_horizontal
By Pulse2
February 6, 2023
IVVD Stock: 7.89% Decrease Explained
The stock price of Invivyd Inc (NASDAQ: IVVD) fell by 7.89% in the most recent trading session. This is why. more_horizontal
By The Motley Fool
January 27, 2023
Why Shares of Invivyd Jumped This Week
The company's shares have climbed along since an FDA announcement earlier this week. more_horizontal
By Zacks Investment Research
January 2, 2023
Invivyd, Inc. (IVVD) Upgraded to Buy: Here's Why
Invivyd, Inc. (IVVD) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive more_horizontal
By Seeking Alpha
November 13, 2022
Invivyd, Inc. (IVVD) CEO David Hering on Q3 2022 Results - Earnings Call Transcript
Invivyd, Inc. (NASDAQ:IVVD ) Q3 2022 Earnings Conference Call November 10, 2022 4:30 PM ET Company Participants Kyra Faircloth - VP, Government Affair more_horizontal